Nuclear medicine imaging to predict response to radiotherapy: a review (Q35035111)

5 August 2017

1 reference

title

Nuclear medicine imaging to predict response to radiotherapy: a review (English)

1 reference

adaptive radiation therapy

5 August 2017

main subject

0 references

Wim Oyen

1 reference

5 August 2017

Otto Boerman

1 reference

5 August 2017

author name string

Christophe Van de Wiele

1 reference

5 August 2017

Christophe Lahorte

1 reference

5 August 2017

Ingeborg Goethals

1 reference

5 August 2017

Guido Slegers

1 reference

5 August 2017

Rudi Andre Dierckx

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

International Journal of Radiation Oncology Biology Physics

5 August 2017

published in

1 reference

5 August 2017

1 reference

5 August 2017

1 reference

5 August 2017

page(s)

5-15

1 reference

Deoxyglucose uptake by a head and neck squamous carcinoma: influence of changes in proliferative fraction

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Positron emission tomography: an independent indicator of radiocurability in head and neck carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Early Prediction of Treatment Outcome in Head and Neck Cancer with 2-18FDG PET

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Detection of DNA Synthesis in Intact Organisms with Positron-Emitting [ Methyl - 11 C]Thymidine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Scintigraphy with positron-emitting compounds.--I. Carbon-11 labeled thymidine and thymidylate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Measurement of short-term 11C-thymidine activity in human head and neck tumours using positron emission tomography (PET)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Non-invasive assessment of tumour cell proliferation with positron emission tomography and [76Br]bromodeoxyuridine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Analysis of 76Br-BrdU in DNA of brain tumors after a PET study does not support its use as a proliferation marker

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Imaging proliferation in vivo with [F-18]FLT and positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

How amino acids get into cells: mechanisms, models, menus, and mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Sugar and amino acid transport by cells in culture--differences between normal and malignant cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

1 reference

7 January 2021

Differential diagnosis of AH109A tumor and inflammation by radioscintigraphy with L-[methyl-11C]methionine.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Evaluation of the malignancy of glioma using 11C-methionine positron emission tomography and proliferating cell nuclear antigen staining.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

PET-Methionine of Skull Base Neuromas and Meningiomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

11C-methionine PET for differential diagnosis of low-grade gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Imaging of head and neck tumors with positron emission tomography and [11C]methionine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Evaluation of early response to radiotherapy in head and neck cancer measured with [11C]methionine-positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Evaluation of the treatment response of lung cancer with positron emission tomography and L-[methyl-11C]methionine: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Suitability of rodent tumor models for experimental PET with L-[1-11C]tyrosine and 2-[18F]fluoro-2-deoxy-D-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

11C-tyrosine position emission tomography and 1H magnetic resonance spectroscopy of the response of brain gliomas to radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Oxygenation predicts radiation response and survival in patients with cervix cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

99Tc(m) labelled HL91 versus computed tomography and biopsy for the visualization of tumour recurrence of squamous head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Evaluation of 62Cu labeled diacetyl-bis(N4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Apoptosis in Irradiated Murine Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

ASTRO Research Fellowship: apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma. American Society for Therapeutic Radiology and Oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Apoptosis and mitosis as prognostic factors in pathologically staged N1 nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Annexin V-Affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Annexin-V imaging for noninvasive detection of cardiac allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Visualisation of cell death in vivo in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Indium-111-labeled anti-EGFr-425 scintigraphy in the detection of malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

In vivo evaluation of epidermal growth factor (EGF) receptor density on human tumor xenografts using radiolabeled EGF and anti-(EGF receptor) mAb 425

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

A histopathological assessment of the response of rectal adenocarcinoma to combination chemo-radiotherapy: relationship to apoptotic activity, p53 and bcl-2 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Apoptosis in carcinoma of the bladder: relation with radiation treatment results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

In vitro radiation-induced apoptosis and early response to low-dose radiotherapy in non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Towards prediction and modulation of treatment response

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Biological predictors of response to radiotherapy in head and neck cancer: recent advances and emerging perspectives.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

ZD1839 ('Iressa'), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904122-6

7 January 2021

10.1016/S0360-3016(02)04122-6

Identifiers

DOI

1 reference

5 August 2017

1 reference